These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 30022811)
1. Development of a tin oxide carrier with mesoporous structure for improving the dissolution rate and oral relative bioavailability of fenofibrate. Bai A; Wu C; Liu X; Lv H; Xu X; Cao Y; Shang W; Hu L; Liu Y Drug Des Devel Ther; 2018; 12():2129-2138. PubMed ID: 30022811 [TBL] [Abstract][Full Text] [Related]
2. Preparation of a Mesoporous Structure of SnO Liu X; Wu C; Bai A; Lv H; Xu X; Cao Y; Shang W; Hu L; Liu Y AAPS PharmSciTech; 2018 Oct; 19(7):3228-3236. PubMed ID: 30187447 [TBL] [Abstract][Full Text] [Related]
3. Development of novel core-shell dual-mesoporous silica nanoparticles for the production of high bioavailable controlled-release fenofibrate tablets. Zhao Z; Gao Y; Wu C; Hao Y; Zhao Y; Xu J Drug Dev Ind Pharm; 2016; 42(2):199-208. PubMed ID: 26114553 [TBL] [Abstract][Full Text] [Related]
4. Fenofibrate Solid Dispersion Processed by Hot-Melt Extrusion: Elevated Bioavailability and Its Cell Transport Mechanism. Wen T; Niu B; Wu Q; Zhou Y; Pan X; Quan G; Wu C Curr Drug Deliv; 2019; 16(6):538-547. PubMed ID: 30674259 [TBL] [Abstract][Full Text] [Related]
5. Mesoporous carbon as a novel drug carrier of fenofibrate for enhancement of the dissolution and oral bioavailability. Niu X; Wan L; Hou Z; Wang T; Sun C; Sun J; Zhao P; Jiang T; Wang S Int J Pharm; 2013 Aug; 452(1-2):382-9. PubMed ID: 23688621 [TBL] [Abstract][Full Text] [Related]
6. Enhancing in vitro dissolution and in vivo bioavailability of fenofibrate by solid self-emulsifying matrix combined with SBA-15 mesoporous silica. Quan G; Wu Q; Zhang X; Zhan Z; Zhou C; Chen B; Zhang Z; Li G; Pan X; Wu C Colloids Surf B Biointerfaces; 2016 May; 141():476-482. PubMed ID: 26896653 [TBL] [Abstract][Full Text] [Related]
7. Dodecylamine Template-Based Hexagonal Mesoporous Silica (HMS) as a Carrier for Improved Oral Delivery of Fenofibrate. Jadhav NV; Vavia PR AAPS PharmSciTech; 2017 Oct; 18(7):2764-2773. PubMed ID: 28353172 [TBL] [Abstract][Full Text] [Related]
8. Development of an oral push-pull osmotic pump of fenofibrate-loaded mesoporous silica nanoparticles. Zhao Z; Wu C; Zhao Y; Hao Y; Liu Y; Zhao W Int J Nanomedicine; 2015; 10():1691-701. PubMed ID: 25784799 [TBL] [Abstract][Full Text] [Related]
9. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol. Zhang Y; Zhi Z; Li X; Gao J; Song Y Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816 [TBL] [Abstract][Full Text] [Related]
10. Modified mesoporous silica nanoparticles for enhancing oral bioavailability and antihypertensive activity of poorly water soluble valsartan. Biswas N Eur J Pharm Sci; 2017 Mar; 99():152-160. PubMed ID: 27993684 [TBL] [Abstract][Full Text] [Related]
11. Preparation of a novel starch-derived three-dimensional ordered macroporous carbon for improving the dissolution rate and oral bioavailability of water-insoluble drugs. Liu Y; Wu C; Hao Y; Xu J; Zhao Y; Qiu Y; Jiang J; Yu T; Ji P J Pharm Biomed Anal; 2016 Jan; 118():267-275. PubMed ID: 26580824 [TBL] [Abstract][Full Text] [Related]
12. Novel electrosprayed nanospherules for enhanced aqueous solubility and oral bioavailability of poorly water-soluble fenofibrate. Yousaf AM; Mustapha O; Kim DW; Kim DS; Kim KS; Jin SG; Yong CS; Youn YS; Oh YK; Kim JO; Choi HG Int J Nanomedicine; 2016; 11():213-21. PubMed ID: 26834471 [TBL] [Abstract][Full Text] [Related]
13. Preparation of a Novel Form of Gelatin With a Three-Dimensional Ordered Macroporous Structure to Regulate the Release of Poorly Water-Soluble Drugs. Xu J; Zhao Z; Hao Y; Zhao Y; Qiu Y; Jiang J; Yu T; Ji P; Liu Y; Wu C J Pharm Sci; 2016 Sep; 105(9):2940-2948. PubMed ID: 26906173 [TBL] [Abstract][Full Text] [Related]
14. Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation. Yousaf AM; Kim DW; Oh YK; Yong CS; Kim JO; Choi HG Int J Nanomedicine; 2015; 10():1819-30. PubMed ID: 25784807 [TBL] [Abstract][Full Text] [Related]
15. A Comparative Study of the Use of Mesoporous Carbon and Mesoporous Silica as Drug Carriers for Oral Delivery of the Water-Insoluble Drug Carvedilol. Han C; Huang H; Dong Y; Sui X; Jian B; Zhu W Molecules; 2019 May; 24(9):. PubMed ID: 31067732 [TBL] [Abstract][Full Text] [Related]
16. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability. Ige PP; Baria RK; Gattani SG Colloids Surf B Biointerfaces; 2013 Aug; 108():366-73. PubMed ID: 23602990 [TBL] [Abstract][Full Text] [Related]
17. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs. Li T; Geng T; Md A; Banerjee P; Wang B Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109 [TBL] [Abstract][Full Text] [Related]
18. Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers. Maleki A; Hamidi M Expert Opin Drug Deliv; 2016; 13(2):171-81. PubMed ID: 26636904 [TBL] [Abstract][Full Text] [Related]
19. Optimization of Nanostructured Lipid Carriers of Fenofibrate Using a Box-Behnken Design for Oral Bioavailability Enhancement. Wang H; Hong W; Li X; Jin Q; Ye W; Feng Y; Huang B; Tai Z; Chen L; Li Z; Wang Y; Yang Y; Gao C; Gong W; Yang M Curr Drug Deliv; 2022; 19(7):773-787. PubMed ID: 33902411 [TBL] [Abstract][Full Text] [Related]
20. Preparation of stabilized submicron fenofibrate crystals on niacin as a hydrophilic hydrotropic carrier. Alshaikh RA; Essa EA; El Maghraby GM Pharm Dev Technol; 2020 Feb; 25(2):168-177. PubMed ID: 31642728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]